Abbott Laboratories, Abbott Park, Ill., has filed a New DrugApplication for a pediatric formulation of its macrolideantibiotic Biaxin (clarithromycin). The company will seekapproval for its use in the treatment of acute otitis media,pharyngitis/tonsillitis, pneumonia and skin and skin structureinfections. Abbott licensed clarithromycin from TaishoPharmaceuticals Co.

(c) 1997 American Health Consultants. All rights reserved.

No Comments